Effects of hydroxychloroquine plus favipiravir treatment on the clinical course and biomarkers in hospitalized covid-19 patients with pneumonia
CONCLUSION: Although the combination of HCQ + FAV treatment was observed to be effective on CRP levels and fever response in patients with COVID-19 pneumonia, there was no difference in terms of hospital stay and discharge.PMID:37492367 | PMC:PMC10364115 | DOI:10.20471/acc.2022.61.03.05
Source: Acta Clinica Croatica - Category: General Medicine Authors: Leman Acun Delen Abdullah Gok Umut Sabri Kasapoglu Ozlem Cagasar Zarife Gok Nurcan Berber Serdar Derya Bora Tetik Source Type: research
More News: Coronavirus | COVID-19 | Croatia Health | General Medicine | Hydroxychloroquine | Laboratory Medicine | Pneumonia | Statistics | Study | Training | Universities & Medical Training